Data Year:

For its 2024 fiscal year, UNIVERSAL HEALTH SVCS INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In Healthcare industry
Alan B. Miller
Executive Chairman
Total Compensation $7,931,946 View details Pay Rank By Title In Healthcare industry #5 View more
Steve G. Filton
Executive Vice President and Chief Financial Officer
Total Compensation $4,952,531 View details Pay Rank By Title In Healthcare industry #10 View more
Marc D. Miller
Chief Executive Officer and President
Total Compensation $14,940,713 View details Pay Rank By Title In Healthcare industry #11 View more
Matthew J. Peterson
Executive Vice President and President, Behavioral Health
Total Compensation $4,132,129 View details Pay Rank By Title In Healthcare industry #9 View more
Edward H. Sim
Executive Vice President and President-Acute Care Division
Total Compensation $4,641,945 View details Pay Rank By Title In Healthcare industry #8 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at UNIVERSAL HEALTH SVCS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. UNIVERSAL HEALTH SVCS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. UNIVERSAL HEALTH SVCS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Alan B. Miller
Executive Chairman
Total Cash $2,163,284 Equity $4,867,232 Other $901,430 $7,931,946
Steve G. Filton
Executive Vice President and Chief Financial Officer
Total Cash $2,579,298 Equity $2,355,795 Other $17,438 $4,952,531
Marc D. Miller
Chief Executive Officer and President
Total Cash $5,624,616 Equity $9,255,605 Other $60,492 $14,940,713
Matthew J. Peterson
Executive Vice President and President, Behavioral Health
Total Cash $2,176,284 Equity $1,935,324 Other $20,521 $4,132,129
Edward H. Sim
Executive Vice President and President-Acute Care Division
Total Cash $2,420,805 Equity $2,202,502 Other $18,638 $4,641,945
For its 2024 fiscal year, UNIVERSAL HEALTH SVCS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Marc D. Miller CEO Pay $15,021,836 Median Employee Pay $53,396 CEO Pay Ratio 281:1
For its 2024 fiscal year, UNIVERSAL HEALTH SVCS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Eileen C. McDonnell Total Cash $346,107
Elliot J. Sussman, M.D. Total Cash $353,607
Maria R. Singer Total Cash $329,857
Nina Chen-Langenmayr Total Cash $324,858
Warren J. Nimetz Total Cash $301,107
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.